H.C. Wainwright analyst Raghuram Selvaraju downgraded Cardiff Oncology (NASDAQ: CRDF) from Buy to Neutral.The analyst comments "Nerviano announces termination of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE